In a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment.
by Pamela Rafalow Grossman
Cancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms.
by Jen Tota McGivney
Patients with advanced cancer often go to rehabilitation facilities after a hospital stay in hopes of gaining the strength for further treatment, but the majority do not go on to receive additional cancer therapy, a study reports.
by Ashley P. Taylor
Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
FORWARD LOOK
Outcomes are often evaluated using progression-free survival.
by Jasenka Piljac Zegarac
Study supports use of single-session, higher-dose radiation.
by Jane Langille
CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.
by Kendall K. Morgan
Researchers look for easier ways to screen for colorectal cancer in Nigeria.
by Bradley Jones
Q&A
Biochemist Samuel H. Sternberg describes the limitations, realities and potential of gene-editing technology.
by Marci A. Landsmann
Nutritional epidemiologist Carrie Daniel-MacDougall discusses research suggesting that what patients eat affects their gut microbes—and could influence cancer immunotherapy response.
by Anna Azvolinsky
The financial burden of a cancer diagnosis can lower a patient’s credit score.
by Shelly Rosenfeld
Cognitive behavioral therapy may help cancer survivors cope with fear of recurrence, some studies say.
by Jon Kelvey
After decades of failed efforts to target the elusive KRAS, encouraging data suggest KRAS could finally be dethroned from the “undruggable” category.
The U.S. Food and Drug Administration has approved an ovarian cancer treatment based on new biomarker.
Lung cancer—one of the most commonly diagnosed cancers in the United States—is an area of intense research and clinical development.
Follow My Lead
donate to the AACR